Kamel Khalili

Q: What Schools Are Affiliated With Kamel Khalili

Kamel Khalili is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, University of Southern California, University of Pittsburgh, Temple University, Thomas Jefferson University

Kamel Khalili's AcademicInfluence.com Rankings

Kamel Khalili

Biology

#7882

World Rank

#10871

Historical Rank

Virology

#167

World Rank

#172

Historical Rank

Molecular Biology

#949

World Rank

#972

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Kamel Khalili Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kamel Khalili's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) (476)
Cellular reservoirs of HIV‐1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry (1996) (442)
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain (2012) (348)
Infectious agents and cancer: criteria for a causal relation. (2004) (333)
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection (2011) (260)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing (2015) (255)
In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models. (2017) (216)
HIV-1 associated dementia: symptoms and causes (2006) (215)
Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. (2002) (202)
A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. (1998) (183)
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice (2019) (182)
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes (2006) (180)
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes (2010) (178)
Purα Is Essential for Postnatal Brain Development and Developmentally Coupled Cellular Proliferation As Revealed by Genetic Inactivation in the Mouse (2003) (174)
Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease (2002) (173)
Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. (1999) (173)
Human Polyomaviruses: Molecular and Clinical Perspectives (2002) (171)
Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat (1999) (171)
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. (1990) (163)
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. (2004) (163)
Early Olfactory Involvement in Alzheimer’s Disease (2003) (162)
Pathogenesis of progressive multifocal leukoencephalopathy--revisited. (2011) (154)
Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms (2014) (154)
Human neurotropic polyomavirus, JCV, and its role in carcinogenesis (2003) (153)
Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. (2001) (152)
Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy (2006) (149)
Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. (2005) (145)
Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. (2000) (139)
Detection of JC virus DNA fragments but not proteins in normal brain tissue (2008) (129)
Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. (1996) (126)
Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. (2002) (125)
CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs (2015) (122)
Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* (2000) (119)
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. (2004) (118)
Purα: A multifunctional single-stranded DNA- and RNA-binding protein (2000) (118)
Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity (2009) (118)
Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen* (2002) (117)
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. (2011) (116)
CCL8/MCP‐2 is a target for mir‐146a in HIV‐1‐infected human microglial cells (2010) (116)
Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. (1995) (115)
Class III &bgr;-Tubulin Is Constitutively Coexpressed With Glial Fibrillary Acidic Protein and Nestin in Midgestational Human Fetal Astrocytes: Implications for Phenotypic Identity (2008) (113)
Regulation of the host range of human papovavirus JCV. (1987) (111)
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells (2002) (111)
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study (2016) (109)
Human polyomaviruses and brain tumors (2005) (107)
Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease (2018) (107)
TAR‐independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV‐1 gene regulation. (1992) (106)
Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals (1999) (105)
Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1α Expression* (2009) (105)
Persistence and pathogenesis of the neurotropic polyomavirus JC (2015) (105)
Regulation of Gene Expression in Primate Polyomaviruses (2009) (105)
Activation of human B-MYB by cyclins. (1997) (104)
Interaction of JC Virus Agno Protein with T Antigen Modulates Transcription and Replication of the Viral Genome in Glial Cells (2001) (102)
Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. (1995) (102)
Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma (2005) (101)
IKKγ protein is a target of BAG3 regulatory activity in human tumor growth (2010) (100)
Cooperative Actions of HIV-1 Vpr and p53 Modulate Viral Gene Transcription* (1998) (97)
The agnoprotein of polyomaviruses: A multifunctional auxiliary protein (2005) (97)
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. (1990) (96)
Reactivation of JC virus and development of PML in patients with multiple sclerosis (2007) (96)
Role of Purα in targeting mRNA to sites of translation in hippocampal neuronal dendrites (2006) (96)
The Rapidly Expanding Family of Human Polyomaviruses: Recent Developments in Understanding Their Life Cycle and Role in Human Pathology (2013) (95)
Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. (1993) (94)
Role of the Insulin-Like Growth Factor I/Insulin Receptor Substrate 1 Axis in Rad51 Trafficking and DNA Repair by Homologous Recombination (2003) (94)
Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. (1992) (94)
Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. (1996) (92)
Multiple roles for Pur-α in cellular and viral regulation (2009) (92)
Nuclear Factor Kappa B Signaling Initiates Early Differentiation of Neural Stem Cells (2012) (92)
A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity* (1997) (92)
Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein (2002) (91)
HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity (2017) (91)
Inhibition of HSV-1 Replication by Gene Editing Strategy (2016) (91)
Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells (1995) (90)
A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells (1995) (89)
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication (1994) (89)
Zika virus: An emergent neuropathological agent (2016) (88)
Insulin-like growth factor I receptor activity in human medulloblastomas. (2002) (87)
Regulation of myelin basic protein gene transcription by Sp1 and Purα: Evidence for association of Sp1 and Purα in brain (1999) (86)
Review: JC virus infection of lymphocytes--revisited. (1997) (86)
Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas (2001) (86)
Role of JC Virus Agnoprotein in DNA Repair (2004) (85)
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study (2016) (85)
Morphine treatment of human monocyte‐derived macrophages induces differential miRNA and protein expression: Impact on inflammation and oxidative stress in the central nervous system (2010) (84)
Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. (1996) (84)
BAG3: a new player in the heart failure paradigm (2015) (84)
Aberrant Localization of the Neuronal Class III b-Tubulin in Astrocytomas A Marker for Anaplastic Potential (2001) (83)
The polyomavirus, JCV and its involvement in human disease. (2006) (83)
Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals (2004) (83)
Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein (1997) (82)
Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers (2016) (82)
HIV-1 Vpr Modulates Macrophage Metabolic Pathways: A SILAC-Based Quantitative Analysis (2013) (80)
Reciprocal Interaction between Two Cellular Proteins, Purα and YB-1, Modulates Transcriptional Activity of JCVCY in Glial Cells (1999) (79)
Inhibition of SNAP25 expression by HIV‐1 Tat involves the activity of mir‐128a (2008) (78)
Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein (2002) (78)
The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. (1993) (76)
Genomic analysis of Th1–Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression (2003) (76)
Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. (2003) (76)
Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. (2006) (74)
Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation (1989) (74)
Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. (1998) (73)
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection (2015) (71)
The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription. (1998) (71)
Evidence for BAG3 modulation of HIV‐1 gene transcription (2007) (70)
Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection (2019) (70)
Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus (2001) (69)
JC Virus-Induced Changes in Cellular Gene Expression in Primary Human Astrocytes (2003) (68)
The CRISPR/Cas9 genome editing methodology as a weapon against human viruses. (2015) (67)
p27SJ, a novel protein in St John's Wort, that suppresses expression of HIV-1 genome (2006) (67)
Functional Interaction between JC Virus Late Regulatory Agnoprotein and Cellular Y-Box Binding Transcription Factor, YB-1 (2002) (66)
Interaction between Cell Cycle Regulator, E2F-1, and NF-κB Mediates Repression of HIV-1 Gene Transcription* (1997) (66)
Localization of the Neuronal Class III β‐Tubulin in Oligodendrogliomas: Comparison with Ki‐67 Proliferative Index and 1p/19q Status (2002) (65)
Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells (1998) (65)
Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties (2004) (65)
Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat (1992) (65)
Potential Mechanisms of the Human Polyomavirus JC in Neural Oncogenesis (2008) (65)
Progressive multifocal leukoencephalopathy: clinical and molecular aspects (2012) (65)
Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. (1990) (64)
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice (2018) (64)
Medulloblastomas and the human neurotropic polyomavirus JC virus (1999) (64)
Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store (2012) (63)
Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. (1995) (63)
GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. (1993) (63)
Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha (1996) (63)
Nuclear factors in human brain cells bind specifically to the JCV regulatory region. (1988) (63)
A developmentally regulated DNA-binding protein from mouse brain stimulates myelin basic protein gene expression (1993) (62)
Developmental Expression of Wnt Signaling Factors in Mouse Brain (2002) (62)
T‐antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS‐1 and Rad51 (2006) (62)
Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy (2014) (62)
Activation of PPARα inhibits IGF‐I‐mediated growth and survival responses in medulloblastoma cell lines (2008) (62)
Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. (2000) (61)
The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. (1989) (61)
Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1 (1996) (61)
Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes* (2004) (61)
Interaction of the Single-stranded DNA-binding Protein Purα with the Human Polyomavirus JC Virus Early Protein T-antigen* (1998) (61)
Cdk9 phosphorylates p53 on serine 392 independently of CKII (2006) (60)
Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. (2007) (60)
Interaction between JCV large T-antigen and β-catenin (2004) (60)
Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. (1999) (59)
Viruses and cancer: lessons from the human polyomavirus, JCV (2003) (59)
Tubulin-Mediated Binding of Human Immunodeficiency Virus-1 Tat to the Cytoskeleton Causes Proteasomal-Dependent Degradation of Microtubule-Associated Protein 2 and Neuronal Damage (2006) (59)
Physical and Functional Interaction between the Y-Box Binding Protein YB-1 and Human Polyomavirus JC Virus Large T Antigen (1999) (59)
Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes (2017) (58)
Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. (2001) (58)
Identification of a Sequence-specific Single-stranded DNA Binding Protein That Suppresses Transcription of the Mouse Myelin Basic Protein Gene (*) (1995) (58)
Translational regulation of SV40 early mRNA defines a new viral protein (1987) (57)
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes. (2016) (57)
Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene (1994) (57)
Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice (2000) (57)
Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus (2006) (57)
Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. (1993) (56)
Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation (2008) (55)
Growth inhibition of glioblastoma cells by human Purα (2001) (55)
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. (2003) (55)
Cooperative interaction of C/EBPβ and Tat modulates MCP-1 gene transcription in astrocytes (2005) (54)
Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS (2016) (53)
Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. (2000) (53)
Helix‐destabilizing properties of the human single‐stranded DNA‐ and RNA‐binding protein Purα (2001) (53)
JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors (2004) (52)
Small tumor antigen of polyomaviruses: Role in viral life cycle and cell transformation (2008) (52)
Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. (1999) (52)
Primary Central Nervous System Lymphoma Expressing the Human Neurotropic Polyomavirus, JC Virus, Genome (2004) (52)
Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. (1989) (52)
Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses (2006) (52)
Dysregulation of autophagy by HIV-1 Nef in human astrocytes (2015) (52)
Intracellular Approach for Blocking JC Virus Gene Expression by Using RNA Interference during Viral Infection (2004) (51)
Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals (2018) (51)
Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. (2008) (51)
Human demyelinating disease and the polyomavirus JCV (2006) (50)
A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. (1991) (50)
Association of HIV-1 Tat with the cellular protein, Purα, is mediated by RNA (1999) (49)
Interaction between JCV large T-antigen and beta-catenin. (2004) (49)
Effect of HIV-1 Vpr on cell cycle regulators. (2004) (49)
TAR-independent replication of human immunodeficiency virus type 1 in glial cells (1992) (48)
Phosphorylation Mutants of JC Virus Agnoprotein Are Unable To Sustain the Viral Infection Cycle (2006) (48)
Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1 (1999) (48)
TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2 (2014) (48)
Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. (2001) (48)
Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein. (1996) (47)
Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme (2002) (47)
Evaluation of an autoregulatory tetracycline regulated system (1998) (47)
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection (2018) (47)
SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. (2009) (46)
A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. (1990) (46)
UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. (2016) (46)
Association of Purα with RNAs Homologous to 7 SL Determines Its Binding Ability to the Myelin Basic Protein Promoter DNA Sequence* (1998) (45)
Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat (1994) (45)
Members of the AP-1 Family, c-Jun and c-Fos, Functionally Interact with JC Virus Early Regulatory Protein Large T Antigen (2003) (45)
Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas. (2002) (45)
Alterations of DNA damage repair pathways resulting from JCV infection. (2007) (45)
Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. (2000) (45)
Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3β constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines (2007) (44)
Role of Hexokinase-1 in the survival of HIV-1-infected macrophages (2015) (44)
BAG3 Expression in Glioblastoma Cells Promotes Accumulation of Ubiquitinated Clients in an Hsp70-dependent Manner* (2011) (44)
The pathogenesis of progressive multifocal leukoencephalopathy. (2011) (44)
Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury. (2016) (44)
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. (2003) (44)
Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme (2000) (44)
Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells (2008) (44)
Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr (2016) (44)
Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. (2019) (43)
CRISPR/Cas9 and cancer targets: future possibilities and present challenges (2016) (43)
Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen (2001) (43)
Regulation of Human Polyomavirus JC Virus Gene Transcription by AP-1 in Glial Cells (2003) (43)
Detection of JC polyomavirus DNA sequences and cellular localization of T-antigen and agnoprotein in oligodendrogliomas. (2002) (42)
Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes. (2002) (42)
GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress‐Induced Apoptosis (2016) (42)
BAG3 protein regulates caspase‐3 activation in HIV‐1‐infected human primary microglial cells (2009) (42)
Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. (2007) (42)
Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma (2011) (41)
Interaction of HIV‐1 Tat with Purα in nuclei of human glial cells: Characterization of RNA‐mediated protein‐protein binding (2000) (41)
Negative Feedback Regulation of HIV-1 by Gene Editing Strategy (2016) (41)
T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas. (2003) (41)
Integrin involvement in glioblastoma multiforme: Possible regulation by NF‐κB (2000) (40)
MyEF-3, a developmentally controlled brain-derived nuclear protein which specifically interacts with myelin basic protein proximal regulatory sequences. (1998) (40)
Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. (2003) (40)
WW Domain of BAG3 Is Required for the Induction of Autophagy in Glioma Cells (2015) (40)
Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy (2011) (40)
HIV-1 Tat Elongates the G1 Phase and Indirectly Promotes HIV-1 Gene Expression in Cells of Glial Origin* (1998) (40)
Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. (2004) (39)
Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines (1994) (39)
Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus. (1987) (39)
JC virus large T‐antigen and IGF‐I signaling system merge to affect DNA repair and genomic integrity (2006) (39)
Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. (1996) (38)
Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. (2004) (38)
Modulation of JC virus transcription by C/EBPbeta. (2009) (38)
Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression (1999) (38)
HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression (2004) (38)
Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat. (1998) (38)
A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus (1992) (38)
CRISPR based editing of SIV proviral DNA in ART treated non-human primates (2020) (38)
Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity (2018) (37)
Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus (2006) (37)
Genome editing strategies: potential tools for eradicating HIV-1/AIDS (2015) (37)
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. (2006) (37)
HIV-1 Vpr deregulates calcium secretion in neural cells (2009) (37)
JC virus in Experimental and Clinical Brain Tumorigenesis (2002) (37)
Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter. (2005) (37)
TNF Alpha Production in Morphine-Treated Human Neural Cells Is NF-κB-Dependent (2009) (37)
Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. (2010) (37)
Evidence for Regulation of Long Terminal Repeat Transcription by Wnt Transcription Factor TCF-4 in Human Astrocytic Cells (2002) (37)
Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. (2005) (36)
HIV-1 Tat protein induces glial cell autophagy through enhancement of BAG3 protein levels (2014) (36)
Actin mRNAs in HeLa cells. Stabilization after adenovirus infection. (1984) (36)
Regulation of TNFalpha and TGFbeta-1 gene transcription by HIV-1 Tat in CNS cells. (1998) (36)
Molecular biology and immunoregulation of human neurotropic JC virus in CNS (2002) (36)
Transdominant Activity of Human Immunodeficiency Virus Type 1 Vpr with a Mutation at Residue R73 (2000) (35)
Myelin basic protein gene transcription. Identification of proximal and distal cis-acting regulatory elements. (1990) (35)
Tumor pathogenesis of human neurotropic JC virus in the CNS. (1998) (35)
Functional interaction between cyclin T1/cdk9 and Purα determines the level of TNFα promoter activation by Tat in glial cells (2001) (35)
Human polyomavirus JCV late leader peptide region contains important regulatory elements. (2006) (35)
Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. (1991) (35)
Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells. (1997) (34)
Identification of a cellular protein that binds to tat‐responsive element of TGFβ‐1 promoter in glial cells (1997) (34)
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. (2008) (34)
Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas (2001) (34)
The gene encoding the large subunit of human RNA polymerase II. (1985) (33)
A 23-bp Sequence Element from Human Neurotropic JC Virus Is Responsive to NF-κB Subunits (1999) (33)
The human polyomavirus, JCV, and neurological diseases (review). (1998) (33)
Association of p65 and C/EBPβ with HIV‐1 LTR modulates transcription of the viral promoter (2007) (33)
Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy. (2003) (32)
A novel role of Rac1 GTPase in JCV T-antigen-mediated β-catenin stabilization (2007) (32)
HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway (2016) (31)
JC Virus Agnoprotein Inhibits In Vitro Differentiation of Oligodendrocytes and Promotes Apoptosis (2007) (31)
Interplay between cdk9 and NF-κB factors determines the level of HIV-1 gene transcription in astrocytic cells (2002) (31)
Reciprocal transactivation between HIV-1 and other human viruses. (2006) (31)
The Rb family of cell cycle regulatory factors: clinical implications. (2000) (31)
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag (2012) (30)
Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells (1996) (30)
Haplo‐insufficiency of Bcl2‐associated athanogene 3 in mice results in progressive left ventricular dysfunction, β‐adrenergic insensitivity, and increased apoptosis (2018) (30)
Evidence for inhibition of MyEF‐2 binding to MBP promoter by MEF‐1/Pur α (1997) (30)
Activation of early gene transcription in polyomavirus BK by human immunodeficiency virus type 1 Tat. (2006) (30)
HIV-1 Latency and Eradication: Past, Present and Future. (2016) (30)
Polymorphisms of the BK virus subtypes and their influence on viral in vitro growth efficiency. (2010) (29)
Inhibition of NF‐κB activity by HIV‐1 Vpr is dependent on Vpr binding protein (2013) (29)
p73 Interacts with Human Immunodeficiency Virus Type 1 Tat in Astrocytic Cells and Prevents Its Acetylation on Lysine 28 (2005) (29)
Adeno-Associated Virus Serotype 9–Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts With Left Ventricular Dysfunction Secondary to a Myocardial Infarction (2016) (29)
Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing (2016) (29)
Brain tumors and polyomaviruses (2003) (28)
T-CELL AND NEURONAL APOPTOSIS IN HIV INFECTION: IMPLICATIONS FOR THERAPEUTIC INTERVENTION (2004) (28)
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element. (2012) (28)
Identification of a novel protein from glial cells based on its ability to interact with NF‐κB subunitsr (2003) (28)
Estrogen receptor β‐mediated nuclear interaction between IRS‐1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma (2009) (28)
A novel role of Rac1 GTPase in JCV T-antigen-mediated beta-catenin stabilization. (2007) (27)
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy (2017) (27)
How does a normal human cell become a cancer cell? (2003) (27)
Isolation and characterization of human actin genes cloned in phage lambda vectors. (1983) (27)
Autoregulation of co‐chaperone BAG3 gene transcription (2009) (27)
Epigenetic regulation of polyomavirus JC (2013) (27)
Suppression of HIV-1 transcription and replication by a Vpr mutant (1999) (27)
The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease. (2013) (27)
Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: Implication for HIV-associated dementia (2005) (27)
Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of Progressive Multifocal Leukoencephalopathy (2009) (27)
Single‐stranded nucleic acid‐binding protein, Purα, interacts with RNA homologous to 18S ribosomal RNA and inhibits translation in vitro (2001) (26)
JC Virus T-Antigen Regulates Glucose Metabolic Pathways in Brain Tumor Cells (2012) (26)
Cell cycle regulation of NF-κB-binding activity in cells from human glioblastomas (2001) (26)
The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. (1994) (26)
Homologous Recombination Rad 51 Trafficking and DNA Repair by I / Insulin Receptor Substrate 1 Axis in Role of the Insulin-Like Growth Factor (2003) (25)
Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics. (2018) (25)
The Role of Vpr in the Regulation of HIV-1 Gene Expression (2006) (25)
Carboxyl-terminal mutants of the large tumor antigen of simian virus 40: a role for the early protein late in the lytic cycle. (1988) (25)
Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell. (1996) (25)
Evidence for phosphatase activity of p27SJ and its impact on the cell cycle (2009) (25)
Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins (2011) (25)
A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat. (1995) (24)
pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation (2002) (24)
Evidence for activation of the TGF-beta1 promoter by C/EBPbeta and its modulation by Smads. (2009) (24)
Cross-Interaction between JC Virus Agnoprotein and Human Immunodeficiency Virus Type 1 (HIV-1) Tat Modulates Transcription of the HIV-1 Long Terminal Repeat in Glial Cells (2006) (24)
TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. (1993) (24)
Human papillomavirus-associated cancers. (2010) (23)
Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region. (1990) (23)
Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat‐induced activation of the HIV‐1 LTR in astrocytes (2006) (23)
JCV agnoprotein‐induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons (2012) (23)
Involvement of the p53 and p73 transcription factors in neuroAIDS (2008) (23)
Dysregulation of mitochondrial bioenergetics and quality control by HIV‐1 Tat in cardiomyocytes (2018) (23)
IGF-IR in neuroprotection and brain tumors. (2009) (23)
Puralpha activates PDGF-A gene transcription via interactions with a G-rich, single-stranded region of the promoter. (2005) (23)
Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. (2002) (22)
Shut-off of actin biosynthesis in adenovirus serotype-2-infected cells. (1984) (22)
The Multifunctional Protein BAG3 (2018) (22)
Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration. (2016) (22)
Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. (1999) (22)
Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation (1999) (22)
Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. (1999) (22)
Retroviruses and the pathogenesis of systemic sclerosis. (1995) (22)
Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review. (1994) (21)
Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells (2011) (21)
Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. (2006) (21)
Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter (1995) (21)
Evidence for involvement of NFBP in processing of ribosomal RNA (2008) (21)
Analysis of the proximal transcriptional element of the myelin basic protein gene. (1992) (21)
MRI-Guided, Noninvasive Delivery of Magneto-Electric Drug Nanocarriers to the Brain in a Nonhuman Primate. (2019) (20)
Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. (2008) (20)
A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. (1999) (20)
CRISPR Editing Technology in Biological and Biomedical Investigation (2017) (20)
Involvement of α1β1 integrin in insulin‐like growth factor‐1‐mediated protection of PC12 neuronal processes from tumor necrosis factor‐α‐induced injury (2006) (20)
TNF‐α/TNFR2 Regulatory Axis Stimulates EphB2‐Mediated Neuroregeneration Via Activation of NF‐κB (2016) (20)
Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen (2001) (20)
HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation (2004) (20)
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells (2012) (20)
Expression of the myelin basic protein gene in transgenic mice expressing human neurotropic virus, JCV, early protein. (1994) (20)
Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses. (2002) (20)
Association of JC Virus Large T Antigen with Myelin Basic Protein Transcription Factor (MEF-1/Purα) in Hypomyelinated Brains of Mice Transgenically Expressing T Antigen (1999) (20)
Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics (2010) (19)
Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing (2018) (19)
HIV‐1 Tat inhibits NGF‐Induced Egr‐1 transcriptional activity and consequent p35 expression in neural cells (2008) (19)
Characterization of glioma-cells derived from human polyomavirus-induced brain-tumors in hamsters. (1995) (19)
St. John's Wort protein, p27SJ, regulates the MCP-1 promoter. (2008) (18)
Regulation of the Pur‐alpha promoter by E2F‐1 (2006) (18)
Epigenetics of µ‐opioid receptors: Intersection with HIV‐1 infection of the central nervous system (2012) (18)
Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape (2016) (18)
Isolation and propagation of primary human and rodent embryonic neural progenitor cells and cortical neurons. (2013) (18)
Differences in Galpha12- and Galpha13-mediated plasma membrane recruitment of p115-RhoGEF. (2009) (18)
MEKK1-MKK4-JNK-AP1 Pathway Negatively Regulates Rgs4 Expression in Colonic Smooth Muscle Cells (2012) (18)
IRS‐1–Rad51 nuclear interaction sensitizes JCV T‐antigen positive medulloblastoma cells to genotoxic treatment (2006) (18)
Evidence for modulation of BAG3 by polyomavirus JC early protein. (2009) (17)
Oncogenic potential of human neurotropic papovavirus, JCV, in CNS. (1998) (17)
RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells. (2010) (17)
An overview: Human polyomavirus JC virus and its associated disorders (2011) (17)
Cardiac Dysfunction in HIV‐1 Transgenic Mouse: Role of Stress and BAG3 (2015) (17)
Suppression of HIV‐1 transcriptional elongation by a DING phosphatase (2011) (17)
Evidence for the involvement of purα in response to DNA replication stress (2007) (17)
Insulin-like Growth Factor I Receptor Activity in Human Medulloblastomas 1 (2002) (17)
Detection of human polyomavirus proteins, T‐antigen and agnoprotein, in human tumor tissue arrays (2010) (17)
Novel AIDS therapies based on gene editing (2017) (17)
Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression (1986) (17)
Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy. (2001) (16)
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy (2016) (16)
p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes (2005) (16)
BAG3 expression is sustained by FGF2 in neural progenitor cells and impacts cell proliferation (2010) (16)
Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. (2008) (16)
Polyomavirus Nephropathy in Kidney Transplantation (2004) (16)
The agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells. (2014) (16)
Negative regulation of AbetaPP gene expression by pur-alpha. (2008) (16)
Self‐association of Purα is mediated by RNA (1999) (16)
Human Neurotropic JC Virus and Its Association with Brain Tumors (2002) (16)
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil. (1998) (16)
Polyomavirus nephropathy in kidney transplantation. (2004) (16)
Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin (2008) (16)
Negative Regulation of AβPP Gene Expression by Pur-alpha (2008) (16)
C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9. (2007) (16)
Interplay between NFBP and NF-kappaB modulates tat activation of the LTR. (2005) (15)
Neurotropic Viral Infections: JC virus molecular biology and the human demyelinating disease, progressive multifocal leukoencephalopathy (2008) (15)
Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription (2001) (15)
Regulation of human neurotropic JCV in colon cancer cells. (2006) (14)
Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components (2008) (14)
An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells (2019) (14)
Neuroprotective Activity of pDING in Response to HIV‐1 Tat (2014) (14)
Viral Oncology: Basic Science and Clinical Applications (2009) (14)
Interaction between serine phosphorylated IRS‐1 and β1‐integrin affects the stability of neuronal processes (2007) (14)
Cross‐talk between T‐Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma (2010) (14)
Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine. (2019) (14)
Role of Bcl2-associated Athanogene 3 in Turnover of Gap Junction Protein, Connexin 43, in Neonatal Cardiomyocytes (2019) (14)
Regulation of Puralpha gene transcription: evidence for autoregulation of Puralpha promoter. (2001) (13)
Growth inhibition of malignant glioblastoma by DING protein (2012) (13)
A texture-based methodology for identifying tissue type in magnetic resonance images (2008) (13)
DING Proteins from Phylogenetically Different Species Share High Degrees of Sequence and Structure Homology and Block Transcription of HIV-1 LTR Promoter (2013) (13)
Basic and clinical research in polyomavirus nephropathy. (2004) (13)
T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection. (2004) (13)
A Bifunctional Intronic Element Regulates the Expression of the Arginine/Lysine Transporter Cat-1 via Mechanisms Involving the Purine-rich Element Binding Protein A (Purα)* (2009) (13)
Interplay between NFBP and NF‐κB modulates tat activation of the LTR (2005) (13)
Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells. (1996) (13)
Age‐related neurodegenerative diseases (2020) (13)
Mitochondrial dysfunction in human immunodeficiency virus‐1 transgenic mouse cardiac myocytes (2018) (13)
Network analysis of hippocampal neurons by microelectrode array in the presence of HIV‐1 Tat and cocaine (2018) (13)
Regulation of mouse myelin basic protein gene transcription by a sequence-specific single-stranded DNA-binding protein in vitro. (1995) (13)
Activation of HIV-1 LTR by Rad51 in microglial cells (2010) (13)
In vivo validation of tissue segmentation based on a 3D feature map using both a hamster brain tumor model and stereotactically guided biopsy of brain tumors in man (1998) (13)
Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma (2012) (13)
Study 3: Early Steroid Cessation-Avoidance Regimens Are Associated With a Lower Incidence of Polyomavirus Nephropathy Compared With Steroid-Based Immunosuppression in Kidney Transplant Recipients (2003) (13)
Cell cycle regulation of NF-kappa b-binding activity in cells from human glioblastomas. (2001) (12)
Purα as a cellular co‐factor of Rev/RRE‐mediated expression of HIV‐1 intron‐containing mRNA (2008) (12)
Simian virus 40, human infections, and cancer: emerging concepts and causality considerations. (2010) (12)
Utililization of experimental animal model for correlative multispectral MRI and pathological analysis of brain tumors. (1999) (12)
Interaction between the pura and E2F-1 transcription factors. (2004) (12)
Polyomaviruses and cancer--interplay between viral proteins and signal transduction pathways. (2004) (12)
MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion (2006) (12)
Dysregulation of NGF‐signaling and Egr‐1 expression by Tat in neuronal cell culture (2006) (11)
Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis (2016) (11)
Animal Models for Progressive Multifocal Leukoencephalopathy (2015) (11)
Involvement of alpha1beta1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-alpha-induced injury. (2006) (11)
Protective role of Puralpha to cisplatin. (2008) (11)
Protective role of Purα to cisplatin (2008) (11)
Interplay of Rad51 with NF-κB Pathway Stimulates Expression of HIV-1 (2014) (11)
Human polyomavirus JCV and expression of myelin genes. (2000) (11)
Rad51 Activates Polyomavirus JC Early Transcription (2014) (11)
Human polyomavirus, JC virus, and progressive multifocal leukoencephalopathy. (2005) (10)
Nuclear proteins in mouse brain cells bind specifically to the myelin basic protein regulatory region. (1990) (10)
p38SJ, a novel DINGG protein protects neuronal cells from alcohol induced injury and death (2009) (10)
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection. (2003) (10)
Oncogenic potential of human neurotropic virus: laboratory and clinical observations. (2001) (10)
Interplay between the retinoblastoma related pRb2/p130 and E2F‐4 and ‐5 in relation to JCV‐TAg (2007) (9)
Development of a bidirectional caspase-3 expression system for the induction of apoptosis (2008) (9)
Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle. (2010) (9)
Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders (2014) (9)
Signaling pathways and polyomavirus oncoproteins: Importance in malignant transformation (2004) (9)
Isolation and characterization of MRF-1, a brain-derived DNA-binding protein with a capacity to regulate expression of myelin basic protein gene. (1994) (9)
Regulation of Purα gene transcription: Evidence for autoregulation of Purα promoter * (2001) (8)
Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. (2005) (8)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR / Cas 9 Gene Editing SUPPLEMENTARY MATERIALS (2016) (8)
Self-association of Puralpha is mediated by RNA. (1999) (8)
Stimulation of alpha 1 (I) procollagen gene expression in NIH-3T3 cells by the human T cell leukemia virus type 1 (HTLV-1) Tax gene. (1995) (8)
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65 (2015) (8)
Generation and characterization of JCV permissive hybrid cell lines. (2009) (8)
Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies (2019) (7)
Re: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories by Rollison et al. (published online 21 October 2004) (2005) (7)
Gene Editing for Treatment of Neurological Infections (2016) (7)
Outcomes of patients with rejection post-polyomavirus nephropathy. (2005) (7)
Precision Medicine for Heart Failure: Lessons From Oncology. (2017) (7)
The transcription factor E2F-1 modulates TGF-β1 RNA expression in glial cells (1997) (7)
Compartmentalized neuronal cultures. (2013) (7)
Isolation and characterization of a type II JC virus from a brain biopsy of a patient with PML. (1995) (7)
PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging (2021) (7)
Biology and epidemiology of HHV-8. (2010) (6)
Soluble factors secreted by activated T‐lymphocytes modulate the transcription of the immunosuppressive cytokine TGF‐β2 in glial cells (1996) (6)
T-antigen-dependent transcriptional initiation and its role in the regulation of human neurotropic JC virus late gene expression. (1998) (6)
The effect of Maneb on implantation, fecundity rate and the thyroid activity in the rabbit (2007) (6)
Perturbation of synapsins homeostasis through HIV-1 Tat-mediated suppression of BAG3 in primary neuronal cells (2019) (6)
RNA-binding protein HuR regulates RGS 4 mRNA stability in rabbit colonic smooth muscle cells (2010) (5)
Molecular pathobiology of EBV infection. (2010) (5)
Potential Role for Herpesviruses in Alzheimer's Disease. (2020) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
JC virus association with brain tumors: the role of T antigen and insulin-like growth factor 1 in DNA repair fidelity. (2010) (5)
The lncRNA LOC102549805 (U1) modulates neurotoxicity of HIV-1 Tat protein (2020) (5)
Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling. (1998) (5)
Evidence for the impact of BAG3 on electrophysiological activity of primary culture of neonatal cardiomyocytes (2019) (4)
Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress (2021) (4)
Tumor induction by simian and human polyomavirusesArticle (2004) (4)
Novel BAG3 Variants in African American Patients with Cardiomyopathy: Reduced β-Adrenergic Responsiveness in Excitation-Contraction. (2020) (4)
Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice (2020) (4)
Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model (2021) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Morphine‐induced MOR‐1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR‐1X Signaling (2016) (4)
Epstein-Barr virus as a pathogen. (2010) (4)
Differences in G α 12 - and G α 13 -mediated plasma membrane recruitment of p115-RhoGEF (2009) (4)
Persistent Anti-Gag, -Nef, and -Rev IgM Levels as Markers of the Impaired Functions of CD4+ T-Helper Lymphocytes During SIVmac251 Infection of Cynomolgus Macaques (2005) (4)
OUTCOMES OF PATIENTS WITH REJECTION POST POLYOMAVIRUS NEPHROPATHY (2004) (3)
HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. (1999) (3)
The Role of Cis- and Trans-Acting Functions in Simian Virus 40 Gene Regulation (1987) (3)
Greetings for the Second International Conference of Polyomaviruses and Human Diseases: Basic and clinical perspectives (2011) (3)
Human Ubiquitous JCV-CYT-antigen Gene Induces Brain Tumors in Experimental Animals (1998) (3)
The cellular response of JC virus T-antigen-induced brain tumor implants to a Murine intra-ocular model (2000) (3)
Possible association of BK virus with prostate cancer. (2010) (3)
Role of Purα in the cellular response to ultraviolet-C radiation (2010) (3)
Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen (2013) (3)
Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed. (2019) (3)
Neuromodulation of BAG co-chaperones by HIV-1 viral proteins and H2O2: implications for HIV-associated neurological disorders (2021) (3)
Validation of tissue segmentation based on 3D feature map in an animal model of a brain tumor (1996) (3)
Polyomaviruses and Papillomaviruses (2009) (2)
Molecular characterization and chromosomal localization of mouse Purα gene (2000) (2)
Molecular characterization and chromosomal localization of mouse Puralpha gene. (2000) (2)
Pathogenesis of acute and chronic hepatitis C virus infection. (2010) (2)
SURVEY AND SUMMARY Pur α : a multifunctional single-stranded DNA- and RNA-binding protein (2000) (2)
JNV: the journal for basic and clinical scientists with a common goal (1995) (2)
Regulation of myelin basic protein gene transcription: Identification of a distal cis‐acting regulatory element (1995) (2)
Role of JCV agnoprotein in DNA repair (2011) (2)
Involvement of the polyomavirus, JC virus, in colorectal cancer. (2010) (2)
The Human Neurotropic Virus, JCV, and Its Association with CNS Tumors (2000) (2)
Hepatitis B vaccine and hepatocellular carcinoma. (2010) (2)
Cross-talk between lipid homeostasis and endoplasmic reticulum stress in neurodegeneration: Insights for HIV-1 associated neurocognitive disorders (HAND) (2020) (2)
Clinical aspects of HTLV-1-associated cancer. (2010) (1)
Epigenetic regulation of polyomavirus JC (2013) (1)
The role of KSHV in pathogenesis of Kaposis's sarcoma. (2010) (1)
Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive (2014) (1)
Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart (2023) (1)
Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro. (2004) (1)
Fetal Brain Injury Models of Fetal Alcohol Syndrome: Examination of Neuronal Morphologic Condition Using Sholl Assay. (2021) (1)
Molecular biology of HIV-induced CNS disease/HIV disease and clinical investigation (2011) (1)
Role of Bcl2-associated Athanogene 3 in Turnover of Gap Junction Protein, Connexin 43, in Neonatal Cardiomyocytes (2019) (1)
HIV-related lymphoma. (2010) (1)
J-109 Sequential administration of LASER ART and CRISPR-Cas9 can facilitate HIV-1 elimination in humanized mice (2019) (1)
Protein Quality Control in Glioblastoma: A Review of the Current Literature with New Perspectives on Therapeutic Targets (2022) (1)
Molecular immunobiology of hepatitis B-associated viral cancer. (2010) (1)
Polyomaviruses of Humans (2008) (1)
Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV. (1996) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
C / EBP b regulates human immunodeficiency virus 1 gene expression through its association with cdk 9 (2007) (1)
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines (1990) (1)
Issue Information‐ToC (2020) (0)
Genome editing strategies: potential tools for eradicating HIV-1/AIDS (2015) (0)
Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies (2019) (0)
HIV-1-associated malignancy: basic and clinical aspects. (2010) (0)
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy (2017) (0)
Mechanisms of transformation mediated by JCV in human tumors. (2006) (0)
primary tissues and cell lines. modifying activity is detected ubiquitously in Double-stranded RNA unwinding and (2013) (0)
JNV: gets better every year. (2001) (0)
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice. (2023) (0)
C/EBPβ regulates HIV-1 gene expression through its association with cdk9 (2007) (0)
Gerald L Stoner (1943–2002) (2011) (0)
MBP promoter upregulation by activated T cell products (1994) (0)
Polyomaviruses and human neoplasia (2011) (0)
Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection (2019) (0)
transactivation by Tat. vitro and facilitates TAR-independent immunodeficiency virus type 1 transcription in kappa B-binding activity that enhances human Central nervous system-derived cells express a (2013) (0)
Up-regulation by JC virus of HERV-W/MSRV/Syncytin-1 human endogenous retroviruses in astrocytes (2013) (0)
VIRAL LOAD MONITORING IN PATIENTS WITH POLYOMAVIRUS NEPHROPATHY WHO HAVE BEEN TREATED FOR REJECTION EPISODES (2004) (0)
Magneto electric nanoparticle based CRISPR-Cas 9 / gRNA delivery to eradicate latent HIV infection and neuropathology in the brain (2018) (0)
Viral proteins and blood brain barrier (2011) (0)
Effect of histone acetylation on transcriptional regulation of amyloid precursor protein activity (2010) (0)
Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity (2018) (0)
JC virus small tumor antigen promotes S phase entry (2011) (0)
Y-Box Binding Transcription Factor , YB-1 Late Regulatory Agnoprotein and Cellular Functional Interaction between JC Virus (2002) (0)
Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing (2018) (0)
Perturbation of synapsins homeostasis through HIV-1 Tat-mediated suppression of BAG3 in primary neuronal cells (2019) (0)
Compartmentalized Neuronal Cultures. (2021) (0)
Isolation and Propagation of Primary Human and Rodent Embryonic Neural Progenitor Cells and Cortical Neurons. (2021) (0)
Modulation de l'activite de gsk-3beta et ses differentes utilisations (2002) (0)
LAB-METABOLIC PATHWAYS (2012) (0)
OR12,4 IGF-IR-dependent activation of Survivin is required in T-antigen-mediated stimulation of proliferation and survival of neural progenitors (2008) (0)
Comprar Viral Oncology: Basic Science and Clinical Applications | Kuan-Teh Jeang | 9780470379912 | Wiley (2010) (0)
HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway (2016) (0)
Regulation of MSRV (Multiple Sclerosis-associated retrovirus) and syncytin-1 by HIV-1 Tat in PBMC and U-87 MG (2010) (0)
In memoriam: Takis S. Papas, Ph.D. (1935–1999) (2000) (0)
WW domain of BAG 3 is required for the induction of autophagy in glioma cells † Running Title : BAG 3 WW domain and autophagy (2014) (0)
MRI characteristics of Primitive Neuroectodermal Tumors ( PNETs ) in a spontaneous JCV T-antigen transgenic mouse brain tumor model at 7 Tesla (2008) (0)
5th International Conference on Polyomaviruses and Human Diseases: Basic and Clinical Perspectives (2013) (0)
Myelin Basic Protein Gene Transcription IDENTIFICATION OF PROXIMAL AND DISTAL CIS-ACTING REGULATORY (2001) (0)
, Disease Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer (2002) (0)
Could NSP5a3a be a target for head and neck cancer? (2010) (0)
JNV further expands scope (2011) (0)
[9] Strategies for studying transcription regulation of neurotropic viruses in the central nervous system: Lesson from JC virus (1995) (0)
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65 (2015) (0)
P1-207 Regulation of beta-amyloid precursor protein promoter activities by other factors (2004) (0)
Title : Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes (0)
Viral neuro-oncogenesis: Polyomaviruses and brain tumors (2020) (0)
Could NSP5a3a be a target for head and neck cancer (2010) (0)
Vaccine development/Prion disease/Viral-induced tumours (2002) (0)
Gene Editing for Treatment of Neurological Infections (2016) (0)
Polyomavirus JC and Human Cancer: Possible Role of Stem Cells in Pathogenesis (2012) (0)
Role of perivascular macrophages trafficking in HIV associated dementia complex (2011) (0)
Joint Symposium The 2nd International Symposium: Polyomaviruses and Human Diseases and 4th International Symposium for Zoonosis Control “Emerging Virus Infections” (2011) (0)
Astrocyte-Elevated Gene-1 (AEG-1) Is Induced by Hypoxia and Glucose Deprivation and Modulates the Glycolytic Phenotype in Glioblastoma (P02.160) (2013) (0)
Joint Symposium The 2nd International Symposium: Polyomaviruses and Human Diseases and 4th International Symposium for Zoonosis Control “Emerging Virus Infections” (2011) (0)
D-110 Synergism between CRISPR/Cas9 and LASER ART leads to elimination of HIV-1 with no rebound in Humanized Mice (2018) (0)
CellType-Specific Expression ofJCVirusEarlyPromoter Is Determined byPositive andNegative Regulationt (1989) (0)
Nervous System Viral Regulatory Protein T-Antigen in Tumors of the Central Detection of JC Virus DNA Sequences and Expression of the Updated Version (2001) (0)
Neuromodulation of BAG co-chaperones by HIV-1 viral proteins and H2O2: implications for HIV-associated neurological disorders (2021) (0)
Polyomaviruses and Brain Tumors (2003) (0)
P2-136 Lipopolysaccharide (LPS) simultaneously induces the two most important biological markers of Alzheimer's disease (2004) (0)
Reply (2009) (0)
Agnoprotein and its coding sequences play regulatory roles in JC virus gene transcription and replication in glial cells (2011) (0)
A BRAIN TUMOR MODEL IN THE SYRIAN HAMSTER CHARACTERIZED BY TUMOR GROWTH BUT NON-INVASIVENESS (1996) (0)
Nuclear proteins regulating transcription of the myelin basic protein gene (1994) (0)
Isolation and Propagation of Primary Human and Rodent Embryonic and (2021) (0)
Viral proteins and blood brain barrier (2002) (0)
Double-Stranded RNA Unwinding andModifying Activity Is Detected Ubiquitously inPrimary Tissues andCellLines (1990) (0)
NFBP , a novel human protein from glial cells that interacts the NF-kappaB subunits to modulate HIV-1 LTR (2005) (0)
Molecular biology of HIV-induced CNS disease/HIV disease and clinical investigation (2002) (0)
Erratum: Caracciolo V, Reiss K, Crozier‐Fitzgerald C, De Pascali F, Macaluso M, Khalili K, Giordano A. 2007. Interplay between the retinoblastoma related pRb2/p130 and E2F‐4 and ‐5 in relation to JCV‐TAg. J Cell Physiol 212: 96–104 (2010) (0)
Vaccine development/Prion disease/Viral-induced tumours (2011) (0)
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice (2019) (0)
Detection of JC virus DNA sequences and cellular localization of viral products T-antigen and agnoprotein in oligodendrogliomas (2005) (0)
HUMAN MEDULLOBLASTOMAS CONTAIN JC VIRUS SEQUENCES AND EXPRESS T ANTIGEN (1999) (0)
Use of an adenosine A3 receptor agonists for the inhibition of viral replication (2002) (0)
Novel AIDS therapies based on gene editing (2017) (0)
Interplay between Pur α and Egr-1 in the transcriptional regulation of amyloid precursor protein gene expression (2010) (0)
MICROGLIA, ASTROCYTES AND OLIGODENDROCYTES EXPRESS HIV- TAT IN CENTRAL NERVOUS SYSTEM AIDS LESIONS (1999) (0)
Journal of NeuroVirology: A new exanded scope (2011) (0)
Abstract 16634: Bcl2 Associated Athanogene 3 Haplo-insufficiency Decreases Cardiac Function and Attenuates Response to Stress (2017) (0)
TheTumorSuppressor Protein p53Strongly Alters Human Immunodeficiency Virus Type1Replication (1994) (0)
TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2 (2013) (0)
Transcription of Human Immunodeficiency Virus Promoter in CNS-Derived Cells: Effect of TAT on Expression of Viral and Cellular Genes (1995) (0)
Human Brain theVirus-Induced Demyelinating Disease of Leukoencephalopathy , the JC Pathogenesis of Progressive Multifocal (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kamel Khalili?

Kamel Khalili is affiliated with the following schools:

Kamel Khalili's Academic­Influence.com Rankings

Why Is Kamel Khalili Influential?

Kamel Khalili's Published Works

Published Works

What Schools Are Affiliated With Kamel Khalili?

Kamel Khalili's AcademicInfluence.com Rankings